Email us for help
Loading...
Premium support
Log Out
Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.
To be added to the distribution list, please email: DDeCastro@southlakeregional.org
In this episode, Dr. Sharlene Gill will discuss the incorporation of Olanzapine into clinic to help manage anorexia and cancer related weight loss.
Key Opinion Leader:
Dr. Sharlene Gill
Professor of Medicine, UBC Medical Oncologist, BC Cancer - Vancouver Chair, GI Disease Site, Canadian Cancer Trials Group Chair, BC Cancer Medical Advisory Committee President, Canadian Association of Medical Oncologists
Host: Dr. Shaqil Kassam skassam@southlakeregional.org Medical Oncologist Stronach Regional Cancer Centre, Newmarket, Ontario
Outline: 0:00 - Introduction 1:40 – Dr. Sharlene Gill Introduction 3:20 – Current anorexia management strategies. 5:20 - Olanzapine as a new S.O.C. for B.S.C 6:40 - Extrapolation of the data to a Canadian Population 14:30- Implementation in a Canadian practice 27:00 - Patient profile appropriate for Olanzapine.